These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1399950)

  • 1. Comparative in-vitro activity of RP 59500 against clinical bacterial isolates.
    Inoue M; Okamoto R; Okubo T; Inoue K; Mitsuhashi S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():45-51. PubMed ID: 1399950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in-vitro activity of RP 59500 against gram-positive cocci.
    Goto S; Miyazaki S; Kaneko Y
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():25-8. PubMed ID: 1399947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
    Nakashio S; Iwasawa H; Iino S; Shimada J
    Jpn J Antibiot; 1997 Oct; 50(10):844-53. PubMed ID: 9412874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
    Brumfitt W; Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci.
    Singh KV; Malathum K; Murray BE
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3640-3. PubMed ID: 11709359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
    Rybak MJ; Houlihan HH; Mercier RC; Kaatz GW
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1359-63. PubMed ID: 9174199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
    Pechère JC
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of quinupristin/dalfopristin, RP59500, against gram-positive clinical isolates.
    Qadri SM; Ueno Y; Abu Mostafa FM; Halim M
    Chemotherapy; 1997; 43(2):94-9. PubMed ID: 9084917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres.
    Barry AL; Fuchs PC; Brown SD
    J Antimicrob Chemother; 1998 Nov; 42(5):651-5. PubMed ID: 9848451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
    Neu HC; Chin NX; Gu JW
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
    Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of RP 59500.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():39-44. PubMed ID: 1399949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
    Fremaux A; Sissia G; Cohen R; Geslin P
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
    Hoban DJ; Weshnoweski B; Palatnick L; Zhanel CG; Davidson RJ
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():59-65. PubMed ID: 1399952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
    Williams JD; Maskell JP; Shain H; Chrysos G; Sefton AM; Fraser HY; Hardie JM
    J Antimicrob Chemother; 1992 Jul; 30(1):27-37. PubMed ID: 1331019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of teicoplanin against gram-positive cocci.
    Allouch P; Pina P; Chaplain C; Delarbre JM; Geffroy F; Grasmick CP; Marcolin M; Morel A; Pangon B; Rio Y; Sédaillan A
    Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens.
    Noviello S; Ianniello F; Leone S; Esposito S
    J Antimicrob Chemother; 2003 Nov; 52(5):869-72. PubMed ID: 14519672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
    Dubois J; Joly JR
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates.
    Nikolaidis P; Metallidis S; Katikaridou E; Chatzidimitriou M; Kollaras P; Tsona A; Koumentaki E; Tourkantonis A
    J Chemother; 2002 Dec; 14(6):544-6. PubMed ID: 12583543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.